HIGHLAND PEAK CAPITAL, LLC: TEVA PHARMACEUTICAL INDS LTD (TEVA): Quarterly 13F Position History
As of Q2 2026, HIGHLAND PEAK CAPITAL, LLC reported 551,133 shares of TEVA PHARMACEUTICAL INDS LTD (TEVA), worth $18.7M and representing 5.4% of its 13F equity book. Quarter-over-quarter share count change: + 129,980 (+30.9%) . The position first appeared in Q2 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.
- 551,133Shares Held (Latest Filing)
- $18.7MReported Market Value (Latest Filing)
- 5.4%Portfolio Weight (% of 13F Equity Book)
- +129,980Quarter-over-Quarter Share Change
- +$6.0MQuarter-over-Quarter Value Change
- 655,225Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 551,133 | +129,980 | +30.9% | $18.7M | 5.4% | $33.9 |
| Q1 2026 | 421,153 | 20,486 | -4.6% | $12.7M | 5.5% | $30.1 |
| Q4 2025 | 441,639 | 132,146 | -23.0% | $13.8M | 5.3% | $31.2 |
| Q3 2025 | 573,785 | 81,440 | -12.4% | $11.6M | 4.3% | $20.2 |
| Q2 2025 | 655,225 | – | – | $11.0M | 4.5% | $16.8 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did HIGHLAND PEAK CAPITAL, LLC first disclose a TEVA position in 13F-HR filings?
HIGHLAND PEAK CAPITAL, LLC first reported TEVA PHARMACEUTICAL INDS LTD (TEVA) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was HIGHLAND PEAK CAPITAL, LLC's most recent quarter-over-quarter share-count change in TEVA?
Between Q1 2026 and Q2 2026, HIGHLAND PEAK CAPITAL, LLC added 129,980 shares of TEVA (+30.9%), bringing the total reported position to 551,133 shares at a market value of $18.7M.
Does the implied price-per-share represent HIGHLAND PEAK CAPITAL, LLC's cost basis in TEVA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.